Credit Suisse initiated coverage on Pear Therapeutics with a new price target

1/20/22 7:36:22 AM ET

Computer Software: Prepackaged Software

Technology

Credit Suisse initiated coverage of Pear Therapeutics with a rating of Outperform and set a new price target of $11.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PEAR

Date	Price Target	Rating	Analyst
1/26/2022	$5.00	Neutral	B of A Securities
1/20/2022	$11.00	Outperform	Credit Suisse
1/3/2022	$12.00	Buy	BTIG Research
12/29/2021	$13.00	Buy	Citigroup
12/22/2021	$16.00	Buy	Chardan Capital
12/16/2021		Outperform	Cowen & Co.